Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis

Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis

Huaqing Yan, Haiyun Xie, Yufan Ying, Jiangfeng Li, Xiao Wang, Xin Xu, Xiangyi Zheng Department of Urology, First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang Province, China Abstract: Pioglitazone has been reported to increase the risk of bladder cancer but the conclusions of publish...

Full description

Bibliographic Details
Main Authors: Yan H, Xie H, Ying Y, Li J, Wang X, Xu X, Zheng X
Format: Article
Language:English
Published: Dove Medical Press 2018-06-01
Series:Cancer Management and Research
Subjects:
pioglitazone
bladder cancer
meta-analysis
epidemiology
risk factor
Online Access:https://www.dovepress.com/pioglitazone-use-in-patients-with-diabetes-and-risk-of-bladder-cancer--peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/pioglitazone-use-in-patients-with-diabetes-and-risk-of-bladder-cancer--peer-reviewed-article-CMAR

Similar Items